Free Trial
NASDAQ:TBIO

Telesis Bio (TBIO) Stock Price, News & Analysis

Telesis Bio logo
$0.30 0.00 (0.00%)
As of 07/10/2025

About Telesis Bio Stock (NASDAQ:TBIO)

Key Stats

Today's Range
$0.30
$0.30
50-Day Range
$0.01
$0.49
52-Week Range
$0.01
$6.17
Volume
2 shs
Average Volume
6,759 shs
Market Capitalization
$540.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter.

TBIO Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Telesis Bio Announces Departure of Chief Legal Officer
See More Headlines

TBIO Stock Analysis - Frequently Asked Questions

Telesis Bio's stock was trading at $0.40 on January 1st, 2025. Since then, TBIO stock has decreased by 25.0% and is now trading at $0.30.

Telesis Bio, Inc. (NASDAQ:TBIO) posted its quarterly earnings data on Monday, November, 8th. The company reported ($6.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($5.04) by $1.08. The firm earned $2.79 million during the quarter, compared to the consensus estimate of $2.93 million.

Shares of Telesis Bio reverse split on Thursday, May 9th 2024.The 1-18 reverse split was announced on Thursday, May 9th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Telesis Bio (TBIO) raised $100 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 7,700,000 shares at a price of $12.00-$14.00 per share. Citigroup, Leerink Partners and Evercore ISI served as the underwriters for the IPO.

Shares of TBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Telesis Bio investors own include Ford Motor (F), Pfizer (PFE), PayPal (PYPL), SoFi Technologies (SOFI), Plug Power (PLUG) and XPeng (XPEV).

Company Calendar

Last Earnings
11/08/2021
Today
7/11/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TBIO
Previous Symbol
NASDAQ:DNAY
CIK
1850079
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($28.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.72 million
Net Margins
-336.59%
Pretax Margin
-334.81%
Return on Equity
N/A
Return on Assets
-61.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.06

Sales & Book Value

Annual Sales
$225.09 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
2.14

Miscellaneous

Outstanding Shares
1,802,000
Free Float
1,360,000
Market Cap
$540.60 thousand
Optionable
Optionable
Beta
0.96
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:TBIO) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners